Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results

por Fried, Georgeta, Moskovitz, Mor
Publicado 2014

Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature

por Moskovitz, Mor, Wollner, Mira, Haim, Nissim
Publicado 2015

BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors

por Dudnik, Elizabeth, Bar, Jair, Moore, Assaf, Gottfried, Teodor, Moskovitz, Mor, Dudnik, Julia, Shochat, Tzippy, Allen, Aaron M., Zer, Alona, Rotem, Ofer, Peled, Nir, Urban, Damien
Publicado 2021

Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world da...

por Dudnik, Elizabeth, Moskovitz, Mor, Rottenberg, Yakir, Lobachov, Anastasiya, Mandelboim, Rinat, Shochat, Tzippy, Urban, Damien, Wollner, Mira, Nechushtan, Hovav, Rotem, Ofer, Zer, Alona, Daher, Sameh, Bar, Jair
Publicado 2021

Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung

por Dudnik, Elizabeth, Kareff, Samuel, Moskovitz, Mor, Kim, Chul, Liu, Stephen V, Lobachov, Anastasiya, Gottfried, Teodor, Urban, Damien, Zer, Alona, Rotem, Ofer, Onn, Amir, Wollner, Mira, Bar, Jair
Publicado 2021

Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome

por Bar-Sela, Gil, Cohen, Idan, Campisi-Pinto, Salvatore, Lewitus, Gil M., Oz-Ari, Lanuel, Jehassi, Ayellet, Peer, Avivit, Turgeman, Ilit, Vernicova, Olga, Berman, Paula, Wollner, Mira, Moskovitz, Mor, Meiri, David
Publicado 2020

Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12, 2447

por Bar-Sela, Gil, Cohen, Idan, Campisi-Pinto, Salvatore, Lewitus, Gil M., Oz-Ari, Lanuel, Jehassi, Ayellet, Peer, Avivit, Turgeman, Ilit, Vernicova, Olga, Berman, Paula, Wollner, Mira, Moskovitz, Mor, Meiri, David
Publicado 2022

ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data

por Moskovitz, Mor, Dudnik, Elizabeth, Shamai, Sivan, Rotenberg, Yakir, Popovich-Hadari, Noa, Wollner, Mira, Zer, Alona, Gottfried, Maya, Mishaeli, Moshe, Rosenberg, Shoshana Keren, Onn, Amir, Merimsky, Ofer, Urban, Damien, Peled, Nir, Maimon, Natalie, Bar, Jair
Publicado 2022

The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of...

por Raphael, Ari, Onn, Amir, Holtzman, Liran, Dudnik, Julia, Urban, Damien, Kian, Waleed, Cohen, Aharon Y., Moskovitz, Mor, Zer, Alona, Bar, Jair, Rabinovich, Natalie Maimon, Grynberg, Shirly, Oedegaard, Cecilie, Agbarya, Abed, Peled, Nir, Shochat, Tzippy, Dudnik, Elizabeth
Publicado 2022